Identification of HIV-1protease cleavage site in human C1-inhibitor

被引:7
|
作者
Gerencer, M
Burek, V
机构
[1] Univ Zagreb, Univ Hosp, Dept Cellular Immunol, Tissue Typing Ctr, HR-10002 Zagreb, Croatia
[2] Univ Zagreb, Univ Hosp Infect Dis Dr Fran Mihaljevic, Dept Clin Immunol, HR-10002 Zagreb, Croatia
关键词
HIV-1; protease; limited proteolysis; complement proteins; protease cleavage site; pathogenesis;
D O I
10.1016/j.virusres.2004.04.010
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have investigated the ability of HIV-1 protease to cleave human complement proteins of the classical complement pathway: C1q, C2 and C4 as well as the regulatory protein, C1-inhibitor. Purified complement proteins were incubated with recombinant HIV-1 protease in vitro and analyzed by SDS-PAGE and immunoblotting assay. The only cleavage site was found in N-terminal region of C1-inhibitor, and it was located between residues Leu-32 and Phe-33 as determined by amino acid sequence analysis of the 85 kDa proteolyfic fragment after 12 Edman degradation cycles. The HIV-1 protease cleavage sites were not found in C1q, C2 and C4 protein. HIV-1 protease-susceptible site in N-terminal region of C1-inhibitor is very close to the cleavage sites of some other proteases that are able to induce N-terminal proteolysis of the protein. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 100
页数:4
相关论文
共 50 条
  • [41] Cleavage of TANK-Binding Kinase 1 by HIV-1 Protease Triggers Viral Innate Immune Evasion
    Jeremiah, Sundararaj Stanleyraj
    Miyakawa, Kei
    Matsunaga, Satoko
    Nishi, Mayuko
    Kudoh, Ayumi
    Takaoka, Akinori
    Sawasaki, Tatsuya
    Ryo, Akihide
    FRONTIERS IN MICROBIOLOGY, 2021, 12
  • [42] Multi-objective optimization with majority voting ensemble of classifiers for prediction of HIV-1 protease cleavage site
    Palmal, Susmita
    Saha, Sriparna
    Tripathy, Somanath
    SOFT COMPUTING, 2023, 27 (17) : 12211 - 12221
  • [43] The binding of HIV-1 protease inhibitors to human serum proteins
    Schön, A
    Ingaramo, MD
    Freire, E
    BIOPHYSICAL CHEMISTRY, 2003, 105 (2-3) : 221 - 230
  • [44] Multi-objective optimization with majority voting ensemble of classifiers for prediction of HIV-1 protease cleavage site
    Susmita Palmal
    Sriparna Saha
    Somanath Tripathy
    Soft Computing, 2023, 27 : 12211 - 12221
  • [45] Revealing Interaction Mode between HIV-1 Protease and Mannitol Analog Inhibitor
    Yan, Guan-Wen
    Chen, Yue
    Li, Yixue
    Chen, Hai-Feng
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 79 (06) : 916 - 925
  • [46] Citrullination of C1-inhibitor as a mechanism of impaired complement regulation in rheumatoid arthritis
    Martin, Myriam
    Nilsson, Sara C. C.
    Eikrem, David
    Fromell, Karin
    Scavenius, Carsten
    Vogt, Leonie M. M.
    Bielecka, Ewa
    Potempa, Jan
    Enghild, Jan J. J.
    Nilsson, Bo
    Ekdahl, Kristina N. N.
    Kapetanovic, Meliha C. C.
    Blom, Anna M. M.
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [47] Novel heterocyclic analogues of the HIV-1 protease inhibitor, Ritonavir
    Kaye, PT
    Musa, MA
    Nchinda, AT
    Nocanda, XW
    SYNTHETIC COMMUNICATIONS, 2004, 34 (14) : 2575 - 2589
  • [48] MOLECULAR MECHANICS ANALYSIS OF INHIBITOR BINDING TO HIV-1 PROTEASE
    SANSOM, CE
    WU, J
    WEBER, IT
    PROTEIN ENGINEERING, 1992, 5 (07): : 659 - 667
  • [49] THE GAG PRECURSOR CONTAINS A SPECIFIC HIV-1 PROTEASE CLEAVAGE SITE BETWEEN THE NC (P7) AND P1 PROTEINS
    WONDRAK, EM
    LOUIS, JM
    DEROCQUIGNY, H
    CHERMANN, JC
    ROQUES, BP
    FEBS LETTERS, 1993, 333 (1-2) : 21 - 24
  • [50] Saquinavir resistance mechanism of non-active site mutants of HIV-1 Protease
    Prashar, Vishal
    Bihani, Subhash
    Das, Amit
    Ferrer, Jean-Luc
    Hosur, Madhusoodan
    ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2011, 67 : C292 - C293